e 4031 has been researched along with Cardiac Toxicity in 1 studies
E 4031: class III anti-arrhythmia agent; structure given in UD
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhao, Q | 1 |
| Wang, X | 1 |
| Wang, S | 1 |
| Song, Z | 1 |
| Wang, J | 1 |
| Ma, J | 1 |
1 other study available for e 4031 and Cardiac Toxicity
| Article | Year |
|---|---|
Cardiotoxicity evaluation using human embryonic stem cells and induced pluripotent stem cell-derived cardiomyocytes.
Topics: Cardiotoxicity; Cell Differentiation; Drug Discovery; Haloperidol; Human Embryonic Stem Cells; Human | 2017 |